Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007275 |
---|---|
Receipt number | R000008581 |
Scientific Title | Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer |
Date of disclosure of the study information | 2012/02/13 |
Last modified on | 2020/04/01 12:00:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/13 12:07:54 | ||
2 | Update | 2012/02/14 11:02:31 | Key exclusion criteria |
|
3 | Update | 2012/02/14 11:03:08 | Division name |
|
4 | Update | 2012/02/14 11:04:10 | Anticipated trial start date Last follow-up date |
|
5 | Update | 2012/02/14 13:53:12 | Organization Organization Division name Division name TEL |
|
6 | Update | 2012/09/11 10:16:53 | Name of person sending information Name of person sending information |
|
7 | Update | 2013/05/31 13:55:31 | Organization Organization Institute Organization |
|
8 | Update | 2014/02/14 14:42:17 | Email Name of person sending information Name of person sending information |
|
9 | Update | 2015/08/17 16:33:45 | Recruitment status |
|
10 | Update | 2015/08/17 16:39:32 | Last name of contact person Last name of contact person Address Address TEL |
|
11 | Update | 2018/07/25 13:44:46 | Public title |
|
12 | Update | 2019/02/18 11:13:13 | Email Name of primary person or sponsor Organization Organization1 Email1 |
|
13 | Update | 2019/08/20 10:17:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address TEL Division name TEL Tel1 Organization Organization Address Address Tel |
|
14 | Update | 2019/08/20 11:09:53 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
15 | Update | 2019/08/20 11:19:47 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
16 | Update | 2020/04/01 11:59:49 | Other related information Other related information |
|
17 | Update | 2020/04/01 12:00:15 | Recruitment status |